Back
Materialise NV Vs. Aligos Therapeutics Industry Stock Comparison
Buy
65
MTLS
Materialise NV
Last Price:
$5.74
Seasonality Move:
-1.23%
Buy
51
ALGS
Aligos Therapeutics
Last Price:
$8.00
Seasonality Move:
-13.29%
Buy
65
Materialise NV (MTLS)
is a Buy
Is Materialise NV a Buy, Sell or Hold?
-
The current Materialise NV [MTLS] share price is $5.74. The Score for MTLS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
MTLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $7.84. The Score for ALGS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MTLS Stock Price Chart
What is Materialise NV's stock price today?
-
The Materialise NV share price today is $5.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTLS is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $7.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight buying pressure.
MTLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 59.22 | Buy |
Chaikin Money Flow: | -13450 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.42 - 5.7) | Buy |
Bollinger Bands (100): | (4.35 - 6.75) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 57.04 | Buy |
Chaikin Money Flow: | 43757 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.27 - 8.01) | Buy |
Bollinger Bands (100): | (3.83 - 14.63) | Sell |
MTLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.59 | Buy |
20-day SMA: | 5.59 | Buy |
50-day SMA: | 5.4 | Buy |
200-day SMA: | 6.14 | Sell |
8-day EMA: | 5.61 | Buy |
20-day EMA: | 5.55 | Buy |
50-day EMA: | 5.48 | Buy |
200-day EMA: | 5.86 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.5 | Buy |
20-day SMA: | 7.5 | Buy |
50-day SMA: | 6.3 | Buy |
200-day SMA: | 15.28 | Sell |
8-day EMA: | 7.49 | Buy |
20-day EMA: | 7.27 | Buy |
50-day EMA: | 7.46 | Buy |
200-day EMA: | 13.13 | Sell |
Materialise NV Earnings Growth & MTLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.08 per share, and an increase next year of $0.15 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Materialise NV Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |